AMZN
Amazon.com, Inc.
AMZN has the edge over KSS overall, supported by stronger valuation and stronger modeled upside.
KSS
Kohl's Corporation
KSS trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
KSS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
KSS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over KSS in the historical PE scenario, which offers more potential upside but is not a forecast.
KSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $14.11 | -40% |
| Fair | 8.2x | $18.88 | -20% |
| Current | 10x | $23.50 | — |
| Expensive | 11x | $26.18 | +11% |
Historical ranges are pointers, not guarantees.
KSS's PE is in its expensive range at 10x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
KSS Forward outlook
There aren't enough analyst estimates for KSS to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over KSS on earnings, with more consistent year-over-year improvement.
KSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.31 | +25% |
| Q2 2026 | $2.38 | +118% |
| Q1 2026 | $2.38 | +143% |
| Q4 2025 | $1.72 | -23% |
| Q3 2025 | $1.85 | -27% |
| Q2 2025 | $1.09 | -56% |
| Q1 2025 | $0.98 | -66% |
| Q4 2024 | $2.22 | +$3.23 |
KSS's earnings per share have fallen from their peak: $2.31 over the past year, against $6.42 in late 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over KSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over KSS on profitability, with a higher operating margin.
KSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -0.9% |
| Q2 2026 | $3.2B | -2% |
| Q1 2026 | $5.2B | -4.2% |
| Q4 2025 | $3.6B | -3.6% |
| Q3 2025 | $3.5B | -5% |
| Q2 2025 | $3.2B | -4.4% |
| Q1 2025 | $5.4B | -9.4% |
| Q4 2024 | $3.7B | -8.5% |
KSS's revenue fell from its 2020 peak and has held roughly level since: $3.5B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.4 points |
| Q2 2026 | 1.4% | -0.4 points |
| Q1 2026 | 4.1% | +1.8 points |
| Q4 2025 | 2% | -0.6 points |
| Q3 2025 | 7.9% | +3.4 points |
| Q2 2025 | 1.9% | +0.6 points |
| Q1 2025 | 2.3% | -2.7 points |
| Q4 2024 | 2.6% | -1.2 points |
KSS's operating margin was 7.4% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
KSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $490M | -3.5% |
| Q2 2026 | -$158M | +$44M |
| Q1 2026 | $686M | +38% |
| Q4 2025 | $16M | +$339M |
| Q3 2025 | $508M | +260% |
| Q2 2025 | -$202M | -$69M |
| Q1 2025 | $497M | -30% |
| Q4 2024 | -$323M | -$317M |
KSS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over KSS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
KSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +6M shares |
| 1 year | +3.5% | +4M shares |
| 3 years | +6.3% | +7M shares |
| 5 years | -24% | -38M shares |
| Available history | -25% | -39M shares |
KSS has 118M diluted shares, up 3.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | $500M |
| Q3 2022 | — |
| Q2 2022 | $158M |
| Q1 2022 | $548M |
| Q4 2021 | $506M |
| Q3 2021 | $255M |
| Q2 2021 | $46M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
KSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
KSS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
KSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 80.9 | Overbought |
KSS's weekly RSI is 64 (neutral) and its Stochastic is 81 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
KSS PE vs Consumer Cyclical Sector
| Metric | KSS | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 44% below |
| PE % | 75 | 47 | 28 pts above |
KSS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
KSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.8 | 8% above |
| 20 week MA | $19.5 | 20% above |
| 50 week MA | $18.0 | 31% above |
| 100 week MA | $15.0 | 57% above |
| 200 week MA | $19.2 | 22% above |
KSS has climbed back above all five of its weekly moving averages, and it's now 22% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over KSS on returns for 2026, with the stronger performance.
KSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $38.9 | -24% |
| 2021 | $38.9 | $50.2 | +29% |
| 2022 | $50.2 | $25.0 | -50% |
| 2023 | $25.0 | $28.7 | +15% |
| 2024 | $28.7 | $14.4 | -50% |
| 2025 | $14.4 | $21.6 | +50% |
| 2026 YTD | $21.6 | $23.5 | +8.9% |
KSS has finished lower in three of the last six years. It's up 8.9% so far in 2026.